Bioventus (NASDAQ: BVS) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.10 by 50 percent. This is a 87.5 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $132.089 million which beat the analyst consensus estimate of $129.850 million by 1.72 percent. This is a 6.63 percent increase over sales of $123.876 million the same period last year.